S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:PURE

PURE Bioscience (PURE) Stock Price, News & Analysis

$0.10
+0.01 (+11.24%)
(As of 03/27/2024 ET)
Today's Range
$0.09
$0.10
50-Day Range
$0.09
$0.13
52-Week Range
$0.07
$0.17
Volume
24,000 shs
Average Volume
18,569 shs
Market Capitalization
$11.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PURE stock logo

About PURE Bioscience Stock (OTCMKTS:PURE)

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.

PURE Stock Price History

PURE Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Q4 2023 Arcus Biosciences Inc Earnings Call
PURE Bioscience Inc PURE
See More Headlines
Receive PURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/12/2020
Today
3/28/2024
Next Earnings (Estimated)
6/12/2024
Fiscal Year End
7/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous chemical products
Sub-Industry
N/A
Current Symbol
OTCMKTS:PURE
Employees
11
Year Founded
1992

Profitability

Net Income
$-3,960,000.00
Net Margins
-194.80%
Pretax Margin
-124.61%

Debt

Sales & Book Value

Annual Sales
$1.87 million
Book Value
($0.01) per share

Miscellaneous

Free Float
65,145,000
Market Cap
$11.07 million
Optionable
Not Optionable
Beta
0.09

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Robert F. Bartlett (Age 79)
    President, CEO & Director
    Comp: $129.8k
  • Mr. Mark Stuart Elliott (Age 49)
    VP of Finance and Principal Financial & Accounting Officer
    Comp: $180k
  • Mr. Thomas Richard Myers (Age 71)
    Executive VP of Technology & Development and Director
    Comp: $200k

PURE Stock Analysis - Frequently Asked Questions

How have PURE shares performed in 2024?

PURE Bioscience's stock was trading at $0.1297 on January 1st, 2024. Since then, PURE shares have decreased by 23.7% and is now trading at $0.0990.
View the best growth stocks for 2024 here
.

Are investors shorting PURE Bioscience?

PURE Bioscience saw a drop in short interest in March. As of March 15th, there was short interest totaling 400 shares, a drop of 97.7% from the February 29th total of 17,200 shares. Based on an average trading volume of 44,000 shares, the short-interest ratio is presently 0.0 days.
View PURE Bioscience's Short Interest
.

When is PURE Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024.
View our PURE earnings forecast
.

How were PURE Bioscience's earnings last quarter?

PURE Bioscience, Inc. (OTCMKTS:PURE) posted its quarterly earnings data on Thursday, March, 12th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $0.35 million during the quarter. PURE Bioscience had a negative net margin of 194.80% and a negative trailing twelve-month return on equity of 717.03%.

What other stocks do shareholders of PURE Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PURE Bioscience investors own include NVIDIA (NVDA), Boeing (BA), Overstock.com (OSTK), Pure Storage (PSTG), Riot Platforms (RIOT), Enphase Energy (ENPH), Mastercard (MA), Main Street Capital (MAIN), Twilio (TWLO) and

How do I buy shares of PURE Bioscience?

Shares of PURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PURE) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners